CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+1.91%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.7B
AUM Growth
+$98M
(+0.67%)
Cap. Flow
+$48.4M
Cap. Flow
% of AUM
0.33%
Top 10 Holdings %
Top 10 Hldgs %
22.12%
Holding
956
New
63
Increased
332
Reduced
303
Closed
69
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$54.5M |
| 2 |
AstraZeneca
AZN
|
$46.3M |
| 3 |
Autodesk
ADSK
|
$40.5M |
| 4 |
Mercado Libre
MELI
|
$39.4M |
| 5 |
Amazon
AMZN
|
$31.1M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$92.5M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$85.8M |
| 3 |
Alibaba
BABA
|
$60.1M |
| 4 |
Merck
MRK
|
$49.2M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
$48.5M |
Sector Composition
| 1 | Healthcare | 32.1% |
| 2 | Technology | 24.54% |
| 3 | Financials | 9.08% |
| 4 | Communication Services | 8.24% |
| 5 | Consumer Discretionary | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Southern Copper
SCCO
$81.9B
| $19.8M | 0.13% |
300,225
-49,145
| -14% | -$3.24M |
|
|
ISEE
177
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $19.7M | 0.13% |
1,215,272
+539,697
| +80% | +$8.76M |
|
178
Robert Half
RHI
$3.8B
| $19.7M | 0.13% |
195,870
+139,743
| +249% | +$14M |
|
179
HP
HPQ
$27B
| $19.6M | 0.13% |
715,919
+56,769
| +9% | +$1.55M |
|
180
Invitation Homes
INVH
$18.6B
| $19.6M | 0.13% |
510,405
+484,621
| +1,880% | +$18.6M |
|
181
Align Technology
ALGN
$9.76B
| $19.5M | 0.13% |
29,356
-189
| -0.6% | -$126K |
|
182
Kinder Morgan
KMI
$59.4B
| $19.2M | 0.13% |
1,150,421
+70,653
| +7% | +$1.18M |
|
183
Mersana Therapeutics
MRSN
$35.5M
| $19.1M | 0.13% |
80,916
+2,000
| +3% | +$471K |
|
|
XLNX
184
DELISTED
Xilinx Inc
XLNX
| $18.8M | 0.13% |
124,372
| – | – |
|
185
Bank of Montreal
BMO
$89.7B
| $18.7M | 0.13% |
187,726
-899
| -0.5% | -$89.7K |
|
186
Best Buy
BBY
$16.3B
| $18.7M | 0.13% |
177,063
-51,892
| -23% | -$5.49M |
|
187
Cytokinetics
CYTK
$5.95B
| $18.3M | 0.12% |
513,344
| – | – |
|
|
MGLN
188
DELISTED
Magellan Health Services, Inc.
MGLN
| $18.3M | 0.12% |
193,817
| – | – |
|
189
Schlumberger
SLB
$53.7B
| $18.2M | 0.12% |
613,000
+101,225
| +20% | +$3M |
|
|
ITCI
190
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $18.1M | 0.12% |
485,466
+165,979
| +52% | +$6.19M |
|
191
Stanley Black & Decker
SWK
$11.6B
| $18.1M | 0.12% |
103,155
+95,996
| +1,341% | +$16.8M |
|
192
Relay Therapeutics
RLAY
$690M
| $17.7M | 0.12% |
562,938
| – | – |
|
193
Kura Oncology
KURA
$706M
| $17.7M | 0.12% |
946,357
| – | – |
|
|
FRTA
194
DELISTED
Forterra, Inc
FRTA
| $17.3M | 0.12% |
734,897
| – | – |
|
|
UFS
195
DELISTED
DOMTAR CORPORATION (New)
UFS
| $17.2M | 0.12% |
315,996
| – | – |
|
196
KLA
KLAC
$115B
| $17M | 0.12% |
50,774
+7,100
| +16% | +$2.37M |
|
197
United Parcel Service
UPS
$71.6B
| $16.9M | 0.12% |
92,953
-98,728
| -52% | -$18M |
|
198
CytomX Therapeutics
CTMX
$346M
| $16.8M | 0.11% |
3,305,940
+977,587
| +42% | +$4.98M |
|
199
Lam Research
LRCX
$127B
| $16.8M | 0.11% |
294,900
-163,940
| -36% | -$9.33M |
|
200
Nurix Therapeutics
NRIX
$697M
| $16.6M | 0.11% |
554,996
+47,693
| +9% | +$1.43M |
|